CHARLES RIVER LABORATORIES INTERNA (CRL)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for CRL
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| CRL | Director | 73 | ["Former President and Chief Executive Officer of Memorial Sloan-Kettering Cancer Center", "Oversees a research laboratory at Sloan Kettering Institute", "Former Director of Abramson Cancer Center at University of Pennsylvania", "Professor of Medicine and Cancer Biology at University of Pennsylvania", "Board member of Regeneron Pharmaceuticals, Inc.", "Former board member of Merck & Co. Inc.", "Member of Howard Hughes Medical Institute, M.D. Anderson Cancer Center, Ohio State University Comprehensive Cancer Center", "Member of Albert Lasker Medical Research Awards Prize Committee", "Elected member of National Academy of Sciences and National Academy of Medicine", "Founder of three biotechnology companies including Agios Pharmaceuticals"] | [] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| REGN | Director | 73 | ["Former President and Chief Executive Officer of Memorial Sloan Kettering Cancer Center from 2010 to 2022","Co‑founder of Agios Pharmaceuticals, Inc.","Former director of Merck & Co., Inc.","Industry Experience","Executive/Leadership Experience","Science/Biotech Background","Research/Academic Experience","Business Strategy/Operations Experience","Financial Expertise","Member of The National Academy of Sciences","Member of The National Academy of Medicine","Member of The American Academy of Arts and Sciences","Member of The American Society for Clinical Investigation","Member of The Association of American Physicians","Board member of Charles River Laboratories International, Inc."] | ["Corporate Governance and Compliance Committee","Technology Committee"] | 2026 |
| MRK | President and Chief Executive Officer | 64 | ["President and Chief Executive Officer, Memorial Sloan-Kettering Cancer Center"] | ["Research (Chair)"] | 2017 |